Light therapy is frequently demonstrated by clinical trials to be effective to seasonal or non-seasonal major depression. However, the pathway underlying the light effect on mood remains unclear. Since a retino-raphe pathway was previously indicated to modulate 5-HT production, we hypothesize that the retinal projection into dorsal raphe nucleus (DRN) may play an important role in the light therapy for depression.
Introduction
Light is sufficiently powerful to exert an effect on affective states [1, 2] . Such as the duration of sunshine significantly modulated the mood of healthy people through serotonergic activity in their brains [3, 4] . Blue-enriched artificial light in the workplace was able to improve subjective alertness and performance [5, 6] . Moreover, recently clinical trials demonstrated that light therapy was not only effective for seasonal affective disorder (SAD, namely seasonal depression) [7] , but also useful for non-seasonal depression (in which major depressive episode is not obviously associated with seasonal pattern) [8, 9] . Light therapy shows its promising in the treatment of depression with its unique advantageous including fast onset of function, economic low-cost as well as minimal side effect [10, 11] . However, the involved pathway underlying the light effect on mood is not well understood, particularly little is known about the visual pathway with light therapy for non-seasonal depression [12] .
As a key source of serotonin (5-HT), dorsal raphe nucleus (DRN), controls 5-HT release into the forebrain and has a vital role in mood regulation [13, 14] . Currently available antidepressants like selective serotonin reuptake inhibitors (SSRIs) mainly based on the modulation of raphe system to reduce 5-HT turnover [15, 16] . A mouse model with tryptophan hydroxylase-2 (TPH-2) mutation in raphe nucleus, which was analogous to human mutation originally identified in a late-life depression cohort [17] , showed significant depression-like behavior with the functional 5-HT deficiency [18] . On the other hand, the retinal projection into DRN, namely retino-raphe projection, exists in many rodents and primates [19] [20] [21] , including the cat [22] , Sprague Dawley rat [21, 23] , Mongolian gerbil [20, 21] , as well as monkey Cebus apella [19] . Even in the human brainstem an intensive response with the light stimuli can be detected using functional magnetic resonance imaging (fMRI) [2, 24] . Our previous study had indicated that retino-raphe projection could modulate serotonergic tone in DRN and subsequent affective behavior as well [20, 25] . Therefore, it is very likely that the retino-raphe projection may play an important role during the light therapy.
A depressive model induced with a high dose of stress hormone (as corticosterone in rodents) has been widely used to study the relationship between non-seasonal depression and adult neurogenesis [26] [27] [28] [29] [30] . High level of corticosterone could induce depression-like responses in rodents mainly through related glucocorticoid receptors (GR) and corticotrophin releasing factor (CRF) [31] [32] [33] , also probably involved the pathway of phosphorylated cyclic AMP response element binding protein (CREB) and arrestin regulation [26, 32] . In this study, we used a rat model of depression induced by corticosterone administration in order to test the role of retino-raphe projection in the light therapy to non-seasonal depression. Our results revealed that this model was suitable for the study of light therapy and the retino-raphe projection was shown to be underlying the effect of light therapy for non-seasonal depression.
Methods and materials

Animals
Adult male Sprague Dawley (SD) rats (Rattus norvegicus, 250-280 g) were used in this study.
They were kept in a 12:12 light / dark cycle (light cycle with 30-40 lux; dark cycle with ~0 lux) with food and water provided ad libitum (lights onset at 7:00 am; offset at 7:00 pm). All experiments were performed in accordance with policies on the utilization of animals and humans in neuroscience research and approved by the Faulty Committee on the Use of Live Animals in Teaching and Research (CULATR) in The University of Hong Kong, and the counterpart in the Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), China.
Corticosterone and fluoxetine administration Corticosterone (CORT, C2505; Sigma-Aldrich, USA) at a concentration of 40mg/kg dissolved in sesame oil (Sigma-Aldrich, USA) was injected into SD rats for 14 days, according to the method of our previous work [34, 35] . Briefly, a stock emulsion of CORT was prepared daily by vortexing corticosterone in sesame oil for 10 min, followed by 60 min of sonication. Prior to every injection, the emulsion was vortexed briefly and injections were made subcutaneously in the neck region of the rat every 24 h. Control treatment was the same as above, but seasame oil was injected without CORT. The administration of fluoxetine (F132, Sigma-Aldrich, USA) was conducted according to previous reports [25, 36, 37] . Some rats were undergone daily intraperitoneal (ip) injection of fluoxetine for 14 days with the daily CORT injection. Each rat received injection of 10 mg/kg/day fluoxetine dissolved in saline each afternoon, after subcutaneous injection of CORT.
Bright light therapy
During the last 7 days of CORT injection, some rats in light-treated groups received the light therapy (n=6). Under the regular 12:12 L/D cycle of ambient light, blue (470 ± 10 nm) and full white light were respectively provided by light-emitting diodes (LED) placed approximately 30-50 cm above the rat cages. The intensity of LED light (100 ~ 400 lux) was detected by Lux meter (TM-209M, Tenmars, USA). The intensity of ambient light was only around 35 lux. While the intensity of blue light or white light was detected by lux meter at the bottom of the cage with the onset of ambient light, in order to match the real environment when they received the light therapy in morning. The light exposure was performed for 30 min each morning during the last 7 days of CORT injection. Onset of light therapy was at 7:00am each day, with the same onset time of ambient lighting. For an experiment of c-Fos test at the last day, those mice were respectively perfused with deep anesthesia after they were kept at the dark condition for 45 min following the 30 min duration of bright light therapy.
Force swim test (FST)
Rats were placed in a cylindrical glass tank filled with water (21-22 o C) to a depth of 30 -40 cm and the whole test was recorded by video. On the first day, the animals were placed in the cylinder for a 15 minute pre-exposure. Data were collected during a second test conducted 24 hours later. Then the animals were monitored for a period of 5 minutes by trained observers.
The analysis of animal behavior included three types of behavior in the test, namely climbing, swimming and immobility. The definition of behavioral types and more detailed procedure were described previously [35, 38] .
Sucrose preference test (SPT)
At the last four days of CORT or oil injection, the SPT experiment was started. The animals were firstly trained to drink a 1% sucrose solution by exposing them to sucrose solution instead of tap water for 24 h. They then were given a continuous 72 h two-bottle exposure to the 1% sucrose solution bottle and tap water bottle with the left/right location balanced across the cages. In order to prevent the possible deviation, two bottles were kept at same conditions using balanced location and were reversed the left/right location every night. At last 2 days, the bottles were weighed every 24 h at 10:00 am in the morning. The sucrose preference was determined as (Δ weight of sucrose) / ( Δ weight of sucrose +Δ weight of water) × 100 [39] .
Open field test (OFT)
The open field is a square arena (80cm length x 80cm wide x 40cm deep) with metal floors and wooden walls. Rats were placed in the center of the open field and allowed to freely explore the arena during a 10-minute test session. Both central and peripheral activities were measured using an automated video-tracking system. Percent of time in the center was defined as the percent of total time that rats spent at the central 26x26 cm area of the open field. Enhanced exploration of the unprotected central portion of a novel open field and reduced thigmotaxis were correlated with reduced anxiety levels [40] .
Corticosterone detection via ELISA
Blood samples of rats were collected at 19:00 pm, about 1 hour after the last CORT injection on the final day. Rats were anaesthetized and blood samples were collected from their tail vein within 3 min using a heparinized needle. Approximately 0.3 ml of blood was collected into a clean 1.5 ml microcentrifuge tube. Centrifugation (1000 rpm, 30 min and 4 o C) of the samples was conducted then the serum was transferred into clean tubes and stored at -80 o C.
The CORT level was determined via a CorrelateEIA corticosterone kit (Assay design, USA).
It was performed according to the manufacturer's instruction and was described previously [28, 34, 35] .
Selective elimination or activation of retino-rapha circuitry
The method using CTB injection into DRN followed by intraocular injection of anti-CTB-saporin conjugate could specifically eliminate the retino-raphe projection, which was described previously [25] . Briefly, rats were anaesthetized with ip injection of a mixture of ketamine and xylazine (2:1, v/v). They were placed in a stereotaxic apparatus and craniotomy was performed. A Hamilton syringe with a 27G needle was inserted and stereotaxically positioned into the DRN regions, then CTB-conjugated Alexa Fluor 488 was deposited into DRN. The injection volume was 0.8 μ l/animal with 0.2 μ l sesame oil. The surgical area was cleansed and the incised tissues sutured. Three days after CTB injection, the animals were intraocularly injected with anti-CTB-Saporin (1μg saporin toxin /eye, anti-CTB: saporin = 1:1 mol ratio, Advanced Targeting Systems, Inc. San Diego, CA). Injection of anti-CTB-Saporin was also performed for each animal in the anesthetized condition. Eyelids were gently retracted with fingers to allow the eyeball to protrude. The injection was performed using a Hamilton syringe with a 35G needle into the posterior chamber of the eye and the needle was left in place for around 4 minutes. After around 3 weeks of the surgery, the DRN-projecting retinal ganglion cells (RGCs) were specifically eliminated in the retina of each animal. The control animals received DRN injection of CTB, and then intraocular injection of saline instead of anti-CTB-Saporin.
Using a similar method, intraocular injection of AAV8-Syn-HM3q-mCherry was performed into 2 eyes of those rats, meanwhile the AAV8-Syn-mCherry was injected into other rats as control group (n=5). After 3 weeks to express those virus, one cannula (200 mm in diameter, NA: 0.37, RWD, China) was implanted into mid-DRN region (AP: -8.10 mm, ML: -0.00 mm and DV: -6.30 mm). The rats were then given 1-week recovery time before behavioral FST experiment began. They were i.p. injected with CNO (0.5 mg/kg BW, Clozapine N-oxide, C0832, Sigma) 1hr followed by 2 nd section of FST experiment. Saline or fluoxetine injection was also conducted as negative or positive controls (n = 5 rats each group).
Tissue collection and preparation
Following deep anesthesia, rats were perfused with saline (pH 7.4) followed by 4% paraformaldehyde (PFA) in 0.01M phosphate buffer (PB: pH 7.4). Retinas were collected followed by post fixation with 4% PFA for 45 min. Brains were removed from the skulls and (1:1000, P3088, Sigma) as well as rabbit anti-somatostatin (SOM) antibody (1:100, AB5494, Millipore). In addition, stain of anti-glutamate, anti-GAD67 and anti-SOM antibodies on brain sections sometimes used a tyramide signal amplification (TSA, T20934, Molecular probes) kit according to the manufacturer's protocol [45] .
Immunoperoxidase staining
A serial sections including the midbrain raphe complex were used for immunoperoxidase staining. The primary antibodies included those against c-fos (rabbit anti-c-Fos polyclonal antibody, 1:3,000; PC38 (Ab-5), Calbiochem (EMD Chemicals)), tryptophan hydroxylase Laboratories; diluted as the instruction) in the distilled water for 5 min. Finally, sections were washed twice in PBS to stop the reaction, then mounted on microscope slides and mounted with coverslips after dehydrated treatment. The color reaction of the c-Fos immunostaining will be blue-black and localized to the nucleus, whereas TPH immunostaining was orange-brown and localized to the cytoplasm. The immunostaining process of p-CREB
(1:1000), GAD-67 (1:2000) and anti-5HT3A (1:200) was similar to those described above [41, 46] .
DRN location and analysis
Serial brain sections of DRN (30 µm) were obtained from adult male SD rats. One sixth sections were immunostained with a rabbit anti-5HT antibody (S5545, Sigma) or a sheep 
Data analysis
Data were shown as means ± SEM. The student T-test was used for comparisons between two groups, whereas one-way ANOVA was applied to compare three or more groups of data, followed by Newman-Keuls or Tukey multiple comparison test using the Prism 5.0 software.
Tukey multiple comparison test was marked at those results when it was able to choose to conduct further statistics. A probability (P) value of <0.05 was considered at the statistically significant level while the <0.01 was at the remarkably significant level.
Results
Light therapy reversed the depressive-like behavior in the stressed rats caused by corticosterone administration
A rodent model of depression induced by the high level of stress hormone, corticosterone (CORT) with 40 mg/kg/day for 14 days, was able to be evaluated by forced swimming test (FST) (Fig 1 A) , sucrose preference test (SPT) (Fig 1 B) as well as body weight change ( Fig   S1) , respectively. And this type of depressive-like responses caused by high intake of CORT could be reversed by a typical SSRI drug, fluoxetine (10 mg/kg/day for 14 days, Fig 1 A and   B ). Moreover, our data in the FST clearly indicated that both white and blue light therapy were able to significantly reverse the depression-like responses in those stressed rats (Fig 1 C-E and Fig S2) . The blue light therapy was demonstrated to exhibit a better efficacy compared with that of white light therapy at the same intensity (Fig 1 C and D) , especially using the 400 lux blue light therapy (470 nm, 400 lux, 30 min each morning for 7 days; see Fig 1C , E and Movie S1; typically, the change of immobility time at Fig 1E and 2A, p<0 .001, Blue-400 or Saline vs CORT groups). The sucrose preference in the saline-injected group was also enhanced significantly with the blue light therapy (p<0.001, Saline vs CORT groups)
although they had already received the CTB injection into DRN before initiating the light therapy ( Fig 2B) . While revealed by open field test (OFT) (Fig 2 C) , those stressed rats did not display obvious anxiety-like behavior, which was consistent with some previous reports [35, 49] . Neither 100 lux blue light or 100 lux white light exhibited sufficiently significant efficacy (Fig 1 C,D and Fig S2) . The red light of 100 lux that belonged to the highest intensity of red light we could apply with our light source was unable to reverse the immobility time of those depressed rats significantly ( Fig S2 G) .
Hence, it was indicated that the effect resulted from the light therapy for a week was sufficiently effective for those stressed rats to reverse their depressive behavior, in particular using the 400 lux blue light therapy. The rat retinas have been indicated to be very sensitive to the blue light (450 nm -495 nm) through their classical photoreceptors and melanopsin photoreceptor [50, 51] , which could be the main reason for the efficacy of blue light therapy over the white light therapy (Fig 1 E, p<0 .001, Blue-400 vs CORT groups; p<0.05, White-400 vs CORT groups).
Manipulation of retino-raphe circuitry effected on antidepressant function of light therapy
There was a distinct retino-raphe projection in the SD rat including average 700 DRN projecting RGCs each retina ( Fig 3) ; among them, the majority belonged to alpha cells (approximately 72%, Fig 3C and S4) and around 10% melanopsin cells as well ( Fig S4) (Li et al.) . While Saporin (SAP) injection was performed to specifically eliminate their retino-raphe projection prior to the start of light therapy, the number of DRN projecting RGCs dramatically decreased from an average 700 to 150 cells in each retina (Fig 3, p<0 .001, Saline vs SAP group, independent student's t-test). Thus the antidepressant effect from the light therapy for those stressed rats has been significantly attenuated after elimination of their retino-raphe projection; this was strongly supported by behavioral tests including FST and SPT (Fig 2 and Fig S3) . These results suggest retino-raphe projection mediates the effect of light therapy since the elimination of the retino-raphe projection led to the significant attenuation of the antidepressant effect resulted from the light therapy.
It was unable to completely abolish the DRN-projecting RGCs using those saporin treatment, but approximately 80% of DRN projecting RGCs was abolished (Fig 3) , which was similar to some related studies [25, 52] . However, the attenuation of 80% retino-raphe connection was already sufficient to block the antidepressant effect from light therapy as both indicated by FST and SPT (Fig 2 A and B, p<0.001, Saline vs CORT groups; p<0.05, Saline vs SAP groups). It was not surprising that the stressed rats in the SAP-injected group still had a little increase of swimming time resulted from light therapy compared with that in the CORT group without the treatment (Fig S3 A) . The reason was probably due to the ability of remaining DRN-projecting RGCs to still receive some signals from light therapy.
Furthermore, the result of HM3q function to activate retino-raphe circuitry (Fig S3 C) consistently indicated the contribution of retino-raphe circuitry to antidepressant-like effect, also similar to the fluoxetine effect that was as positive control in this FST experiment.
Significant c-Fos change happened in GABA cells in the subregion of DRN with corticosterone administration and light therapy
In terms of the c-Fos expression in the DRN (Fig 4 and Fig S5) , those rats underwent noticeable alteration of c-Fos expression resulted from the high intake of stress hormone and also the effect of light therapy. DRN c-Fos expression was activated by corticorterone administration firstly then suppressed by light stimuli dramatically (Fig 4 and Fig S5) , especially in the lateral wings of middle DRN, namely DRVL parts ( 
5-HT3A coexpressing GABAergic interneurons in DRN mediated the function of light therapy for depression
The change of c-Fos was further supported by the microstructure of DRN in the rat. The distribution of GAD67 positive GABAergic neurons preferred to be located in both of ventrolateral parts of middle DRN (DRVL) ( Fig 5 D and Fig S8 B ), whereas the density of 5-HT neurons in DRVL was significantly lower than in the midline DRN (Fig 5 D) . In agreement with previous study [21, 23] , the retinal fibers from retino-raphe projection also innervated more in the DRVL part of the middle DRN ( . It was implicated that the level of c-Fos expression in 5-HT3A positive GABA cells was most likely to contribute to the light therapy effect through retino-raphe projection.
Discussion
Depression is a serious mood disorder with a high prevalence and complicated pathophysiology [58, 59] . Currently available antidepressant drugs often had their limitations, like a long time lag for efficacy (several weeks or months), body weight gain and leading to sexual dysfunction [60, 61] . Nevertheless, to our knowledge, light profoundly effected on human mood state and cognitive function [1, 2, 62] , and then the light therapy in clinical trials displayed its unique advantageous to treat depression, including fast-onset, low-cost and minor side effect [11] . However, the mechanism underlying them is still not clear so far. The present study revealed that the nerve innervation of retino-raphe projection had a key contribution to the light therapy for this non-seasonal depression model. . This is suggested that it was more likely to benefit from the light therapy conducted in morning with the regular light/dark cycle [68] . A previous study has indicated that light signals could transmit into DRN directly in rats [56] , and our previous work in gerbils has also revealed that light signals with photoreceptor ablation using MNU drug mainly driven by OFF alpha cells could modulate 5-HT production and then the related affective behavior through retino-raphe projection [25] . In this study, the blue light therapy was indicated to exhibit better efficacy than the white light therapy. Main reason was because DRN projecting RGCs in rats contained diverse types, at least 72% alpha cells and 10% melanopsin cells (Fig 3 and Fig 4S) .
Moreover, the rat retinas had been demonstrated to be very sensitive to the blue light (450 nm-495 nm) using their classical photoreceptors and melanopsin photoreceptor together [51]:
the rat rods preferred to ∼ 500 nm [50] , and the rat cones were most sensitive at either 510 nm or 359 nm [69], whereas the intrinsically photosensitive retinal ganglion cells (ipRGCs, namely, melanopsin cells) in rats were most sensitive at 480 nm [51] . All of photoreceptors had some plain spectrum along their peak photosensitivity; then our using blue LED had the wavelength of 470 ± 10 nm belonged to the relatively much sensitive range of rat retina, which could reasonably activate most of retinal neurons especially with the little ambient white light (~35 lux). The 400 lux blue light therapy (470 nm, 400 lux, 30 min each morning for 7 days) had the best effect of light therapy for non-seasonal depression in this study, almost similar to the efficacy of fluoxetine treatment for 14 days (Fig 1, Fig 2 and Fig S3) . So far there was no observational phototoxicity to be found in the retinal neurons following the stimulation of 400 lux blue light, and further evaluation is to conduct.
A recent report indicated that the projection of orexin neurons from the perifornical-lateral hypothalamic area (PF-LHA) into DRN displayed an important pathway in the light therapy, while using the Arvicanthis niloticus (Nile grass rat) as a model of seasonal depression with light deprivation [70] . In that case, the most reason might belong to that the grass rat is naturally lack of a direct connection between retinas and DRN region, unlike a distinct retino-raphe projection located at the SD rat [70, 71] . The immunotoxin induced elimination of the retino-raphe projection (lost 80% DRN projecting RGCs) significantly led to the attenuation of the antidepressant effect from the blue light therapy. This clearly revealed that the contribution from retino-raphe projection to the light therapy for those stressed rats.
Another alterative argument was that after the retino-raphe projection was specifically eliminated, other retinofugal projections in the brain still probably participated in the light 2 0
therapy. This could be the retino-SCN projection which was mainly driven by melanospin cells [72] . Since circadian phase shift due to altered light signal input into suprachiasmatic nucleus (SCN) was regarded as a main responsibility for light therapy to seasonal depression [73] . And the effect of circadian phase shift via photoentrainment was often taken with an advanced or delayed light stimuli [73, 74] . However, our light therapy conducted in those rats with regular light / dark cycle. Then other retinal projections could not be found to be associated with depression more than the retino-raphe projection. Therefore, our data in this study indicated that the rat retino-raphe projection was a key pathway for the function of light therapy to the non-seasonal depression caused by overdose stress hormone.
As an immediate early gene, c-fos with its protein (c-Fos) was often associated with cell depolarization [75, 76] . In this study, our present data indicated that light therapy had a relatively rapid antidepressant effect at a week, compared with that antidepressant fluoxetine with the function onset after 2 weeks [58, 61] ; thus this was less likely to associate with modulation of adult neurogenesis that usually resulted from chronic antidepressant effect [61] . The light stimulation did not significantly induce c-Fos immunoreactivity in the 5-HT neurons, but significantly deactivated the hyperaction of GABAergic interneurons and thus modulated the microcircuitry of DRN serotoninergic system. Light suppression of c-Fos expression was also reported previously but the molecular mechanism was not clear so far [56, 106] . C-Fos expression in glutamatergic neurons, like in the retina was usually implicated a maintenance of synaptic connection and signal transmission as well [107, 108] , whereas GABAergic interneurons with c-Fos expression would be more likely to contribute an inhibitory function to their neighboring neurons [79, 80, 92, 93] . Before the light signals transmitted into the DRN, many GABAergic interneurons have already stayed in the activation state caused by high level of stress hormone, which was similar to the situation in DRN induced by other types of stress stimuli as well as the state of active sleep (namely, rapid eye movement sleep) [43, 77, 109] . The light signals through retino-raphe projection went into the DRN with the light stimuli and that was very likely to activate the arousal response, since the arousal response was a primary function of the DRN serotoninergic system [110, 111] ; and the light stimuli could initiate arousal response rapidly [2, 112, 113] . While Saporin immunotoxin specifically eliminated the retino-raphe projection [25] , the function of light therapy was significantly blocked. Thus the light therapy for non-seasonal depression is more likely to benefit from the light-induced arousal response in DRN serotoninergic system through retino-raphe projection. The function of retino-raphe projection with a natural optogenetics originated from retinal opsins [93, 114, 115] , is not only for non-seasonal depression but might also contribute to seasonal depression and other circuitry-related affective disorders due to the intimate connection between raphe and other emotional areas [116] [117] [118] , and seems to enable most healthy people to benefit from sunshine as well [119, 120] . In future the involved mechanisms on light therapy will be elucidated more thoroughly, which might benefit to understand the depression profoundly and well develop an advanced antidepressant way.
Conclusion
This study indicated the retino-raphe projection had a function to modulate the neural activity in the DRN and contributed to light therapy for a non-seasonal depression model. The light stimulation especially using blue light could reverse the depression-like responses in those stressed rats caused by corticosterone administration. While the retino-raphe projection was largely eliminated using the Saporin immunotoxin, the effect of light therapy was attenuated significantly. During the light therapy for those depressed animals, the light signals through retino-raphe projection deactivated the hyperaction of 5-HT3A positive GABA cells with c-Fos expression that initially resulted from high intake of stress hormone; that eventually contributed to antidepressant effect of light therapy. I  s  h  i  d  a  ,  H  .  H  a  s  h  i  g  u  c  h  i  ,  R  .  T  a  k  e  d  a  ,  Y  .  I  s  h  i  z  u  k  a  ,  Y  .  M  i  t  s  u  y  a  m  a  ,  H  .  K  a  n  n  a  n  ,  T  .  N  i  s  h  i  m  o  r  i  ,  D  .  N  a  k  a  h  a  r  a  ,  C  o  n  d  i  t  i  o  n  e  d  -f  e  a  r  s  t  r  e  s  s  i  n  c  r  e  a  s  e  s  F  o  s  e  x  p  r  e  s  s  i  o  n  i  n  m  o  n  o  a  m  i  n  e  r  g  i  c  a  n  d  G  A  B  A  e  r  g  i  c  n  e  u  r  o  n  s  o  f  t  h  e  l  o  c  u  s  c  o  e  r  u  l  e  u  s  a  n  d  d  o  r  s  a  l  r  a  p  h  e  n  u  c  l  e  i  ,  S  y  n  a  p  s  e  (  N  e  w Open field test. Oil-ctrl: oil injection group, n=18; CORT: corticosterone injection group, n=24; Saline: CTB injection with saline injection, followed by corticosterone injection and blue light therapy (400 lux), n=8; Saporin: CTB injection with saporin injection, followed by corticosterone injection and blue light therapy (400 lux), n=8; Flx: corticosterone injection with fluoxetine treatment, n=6. * P < 0.05, ** P < 0.01, ***p<0.001 vs. CORT group. 
